Epeius Biotechnologies   Report issue

For profit Phase 2
Founded: San Marino CA United States (2000)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2005
NCT00121745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Epeius Clinical Research | Epeius Clinical Research Unit/Sarcoma Oncology Center

Active Ingredients

Drugs in Phase 2 Trials (1)

rexin-g (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Osteosarcoma (Phase 2)

Pancreatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 1